Schwangerschaft nach Brustkrebserkrankung: Ergebnisse eines systematischen Reviews mit Metaanalyse.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works matching IS 01797158 AND DT 2022 AND VI 198 AND IP 8
Results: 12
1
2
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 683, doi. 10.1007/s00066-022-01961-y
- By:
- Publication type:
- Article
3
Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 735, doi. 10.1007/s00066-022-01953-y
- By:
- Publication type:
- Article
4
Phase-II-Studie zur Therapiedeeskalation bei HPV-assoziierten Oropharynxkarzinomen. Kommentar II.
- Published in:
- 2022
- By:
- Publication type:
- Book Review
5
Geschichte der Hypofraktionierung und „die Tabelle an der Wand".
- Published in:
- 2022
- By:
- Publication type:
- Book Review
6
Die Wahl der Chemotherapie unter einer PET-CT-geführten Therapiedeeskalation hat einen signifikanten Einfluss auf die Fertilität und Lebensqualität junger Hodgkin-Patientinnen und Patienten.
- Published in:
- 2022
- By:
- Publication type:
- Book Review
7
Effect of plan complexity on the dosimetry, delivery accuracy, and interplay effect in lung VMAT SBRT with 6 MV FFF beam.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 744, doi. 10.1007/s00066-022-01940-3
- By:
- Publication type:
- Article
8
Radiotherapy in oligometastatic prostate cancer—a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO).
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 727, doi. 10.1007/s00066-022-01925-2
- By:
- Publication type:
- Article
9
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 719, doi. 10.1007/s00066-022-01909-2
- By:
- Publication type:
- Article
10
Radiomics-based prognosis classification for high-risk prostate cancer treated with radiotherapy.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 710, doi. 10.1007/s00066-021-01886-y
- By:
- Publication type:
- Article
11
Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer: An investigation of 117 pelvic lymph nodes.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 700, doi. 10.1007/s00066-021-01871-5
- By:
- Publication type:
- Article
12
On the probability of lymph node negativity in pN0-staged prostate cancer—a theoretically derived rule of thumb for adjuvant needs.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 690, doi. 10.1007/s00066-021-01841-x
- By:
- Publication type:
- Article